Category: CovidienSyndicate content

Matchmaking for medtech: Greenberg Traurig looks to bring companies together

January 21, 2015 by Brian Johnson

Law firm Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day with an eye on putting start-ups and medtech titans together in the same room.

Matchmaking for medtech: Greenberg Traurig looks to bring companies together

You can't do M&A without a little meet & greet.  

Ishrak: 'With COV We'll do for ORs what we've done for cath labs' | The week in medtech M&A

January 14, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'; Medtronic details shareholder votes for Covidien merger; CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014; Medtronic-Covidien merger could close this month; Covidien's Stellarex drug-eluting balloon wins CE Mark

Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'

January 12, 2015 by Brian Johnson

A ventilator Covidien's Nellcor arm attracts another Class I recall | Regulatory news for the week of January 12, 2015

January 13, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Another recall for Covidien's Nellcor ventilator business; MiMedx reveals subpoena, lawsuit against rival, beefs with FDA; Quanta wins CE Mark for portable dialysis device; Cohera Medical wins approvable letter from FDA for TissuGlu surgical sealant; FDA lifts import ban on Hospira infusion pumps

Another recall for Covidien's Nellcor ventilator business

January 6, 2015 by Mark Hollmer

Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'

January 12, 2015 by Brian Johnson

Medtronic CEO Omar Ishrak highlights how the Covidien buyout will enable his company to expand its value-based model into the operating room.

Medtronic CEO Ishrak defends Covidien deal

Almost exactly a year ago Medtronic (NYSE:MDT) CEO Omar Ishrak insisted that value-based healthcare is the salvation, not the damnation, of the medical device industry.

Medtronic-Covidien merger could close this month

January 12, 2015 by Brad Perriello

Medtronic and Covidien could close their $43 billion mega-merger by the end of the month, according to a regulatory filing.

Medtronic-Covidien merger could close this month

Medtronic details shareholder votes for Covidien merger

January 9, 2015 by Brad Perriello

Medtronic's shareholders overwhelmingly approved its proposed, $43 billion merger with Covidien this week, including a controversial provision to cover a portion of its executives tax bills.

Medtronic details shareholder votes for Covidien merger

Covidien's Stellarex drug-eluting balloon wins CE Mark

January 9, 2015 by Brad Perriello

Covidien's Stellarex drug-eluting balloon, which it's slated to deal to Spectranetics after the closure of its buyout by Medtronic, wins CE Mark approval in the European Union.

Covidien's Stellarex drug-eluting balloon wins CE Mark

European regulators granted market clearance for Covidien's (NYSE:COV) Stellarex drug-eluting balloon for treating peripheral artery disease, the company said today.